NCT07262567 2025-12-03Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic CancerGenfleet Therapeutics (Shanghai) Inc.Phase 3 Not yet recruiting320 enrolled